We are live on ! Find out more
EPIM

Evelyn Partners Investment Management Portfolio holdings

AUM $3.68B
1-Year Est. Return 21.15%
This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+21.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.27B
AUM Growth
+$267M
Cap. Flow
+$27.6M
Cap. Flow %
0.84%
Top 10 Hldgs %
47.67%
Holding
438
New
18
Increased
79
Reduced
113
Closed
23

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$25.6M
2
SPGI icon
S&P Global
SPGI
+$18.9M
3
RACE icon
Ferrari
RACE
+$17.1M
4
ROP icon
Roper Technologies
ROP
+$9.7M
5
APH icon
Amphenol
APH
+$7.15M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$16.4M
2
GS icon
Goldman Sachs
GS
+$11.6M
3
AAPL icon
Apple
AAPL
+$11M
4
MCD icon
McDonald's
MCD
+$7.64M
5
V icon
Visa
V
+$6.19M

Sector Composition

Rank Sector Weight
1 Technology 23.97%
2 Financials 20.95%
3 Consumer Discretionary 15.48%
4 Healthcare 11.38%
5 Communication Services 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
376
Baidu
BIDU
$35.6B
$4.63K ﹤0.01%
+54
New +$4.66K
CDZI icon
377
Cadiz
CDZI
$292M
$4.08K ﹤0.01%
1,366
– –
MAT icon
378
Mattel
MAT
$4.19B
$3.94K ﹤0.01%
200
– –
ARQT icon
379
Arcutis Biotherapeutics
ARQT
$3.3B
$3.79K ﹤0.01%
270
– –
GRAL
380
GRAIL Inc
GRAL
$3.08B
$3.6K ﹤0.01%
70
-12
-15% -$434
ALB icon
381
Albemarle
ALB
$15.1B
$3.32K ﹤0.01%
53
– –
AJG icon
382
Arthur J. Gallagher & Co
AJG
$65.5B
$3.2K ﹤0.01%
+10
New +$3.3K
FBIN icon
383
Fortune Brands Innovations
FBIN
$5.83B
$3.09K ﹤0.01%
60
– –
RAL
384
Ralliant Corp
RAL
$8.03B
$2.91K ﹤0.01%
+60
New +$2.96K
APLS
385
DELISTED
Apellis Pharmaceuticals
APLS
$2.6K ﹤0.01%
150
– –
TAK icon
386
Takeda Pharmaceutical
TAK
$55.6B
$2.58K ﹤0.01%
167
– –
KLG
387
DELISTED
WK Kellogg Co
KLG
$2.26K ﹤0.01%
142
– –
NOK icon
388
Nokia
NOK
$57.6B
$1.91K ﹤0.01%
368
– –
NAK
389
Northern Dynasty Minerals
NAK
$953M
$1.62K ﹤0.01%
1,200
– –
UI icon
390
Ubiquiti
UI
$35B
$1.24K ﹤0.01%
3
– –
PRTA icon
391
Prothena Corp
PRTA
$475M
$1.21K ﹤0.01%
199
– –
CC icon
392
Chemours
CC
$2.29B
$1.18K ﹤0.01%
103
-87
-46% -$980
VOO icon
393
Vanguard S&P 500 ETF
VOO
$1.03T
$1.14K ﹤0.01%
2
– –
GDX icon
394
VanEck Gold Miners ETF
GDX
$27.8B
$1.04K ﹤0.01%
20
– –
MOAT icon
395
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$938 ﹤0.01%
10
– –
GEN icon
396
Gen Digital
GEN
$17.1B
$882 ﹤0.01%
30
– –
CEVA icon
397
CEVA Inc
CEVA
$857M
$813 ﹤0.01%
37
– –
LAC
398
Lithium Americas
LAC
$1.18B
$804 ﹤0.01%
300
– –
VHT icon
399
Vanguard Health Care ETF
VHT
$19B
$745 ﹤0.01%
3
– –
EMBC icon
400
Embecta
EMBC
$269M
$717 ﹤0.01%
74
-40
-35% -$450
14 15
16
17 18

Similar funds

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
OIMU
Osmosis Investment Management UK London, United Kingdom $3.72B AUM

Evelyn Partners Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Evelyn Partners Investment Management held 438 positions worth $3.27B, up 8.9% from $3B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Evelyn Partners Investment Management's Q2 2025 filing shows 18 new, 79 increased, 113 reduced and 23 closed positions. Its largest new stake was Yum! Brands: 3,702 shares worth $549K. The largest sale was Thermo Fisher Scientific, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Evelyn Partners Investment Management's largest Q2 2025 buy was Yum! Brands: 3,702 shares worth $549K.
  • Evelyn Partners Investment Management added most to Microsoft in Q2 2025, an estimated $25.6M increase.
  • Evelyn Partners Investment Management's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $16.4M.
  • Evelyn Partners Investment Management fully exited Zscaler in Q2 2025, selling an estimated $174K.
  • Evelyn Partners Investment Management's ten largest holdings make up 48% of its $3.27B portfolio in Q2 2025.
  • Evelyn Partners Investment Management opened 18 new positions and closed 23 in Q2 2025.
  • Evelyn Partners Investment Management's portfolio value rose 8.9% quarter-over-quarter to $3.27B.

Based on Evelyn Partners Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.